Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lindsey Law"'
Autor:
Rachna T. Shroff, Asif Rashid, Jane E. Rogers, Mohamed Elbanan, Ryan M. Bolonesi, Khaled M. Elsayes, Lindsey Law, Ahmed Kaseb
Publikováno v:
Journal of gastrointestinal oncology. 8(2)
Background: Combined hepatocellular-cholangiocarcinoma (HCC-CC) has a reported incidence of less than 5% of primary hepatic malignancies. The treatment approach to this malignancy is undefined. Our objective of this case series is to provide some ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011fec400f74ed0930ea71a78785d790
https://pubmed.ncbi.nlm.nih.gov/28480073
https://pubmed.ncbi.nlm.nih.gov/28480073
Autor:
Lindsey Law, Nilkantha Sen, Lynda D. Hester, Judy V. Nguyen, Makoto R. Hara, Michael D. Kornberg, Krishna R. Juluri, Adele M. Snowman, Solomon H. Snyder
Publikováno v:
Nature cell biology
S-nitrosylation of proteins by nitric oxide is a major mode of signalling in cells. S-nitrosylation can mediate the regulation of a range of proteins, including prominent nuclear proteins, such as HDAC2 (ref. 2) and PARP1 (ref. 3). The high reactivit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15269615de2f4b99fcaec4fc2f9a797b
https://doi.org/10.1038/ncb2114
https://doi.org/10.1038/ncb2114
Autor:
Jane E, Rogers, Lindsey, Law, Van D, Nguyen, Wei, Qiao, Milind M, Javle, Ahmed, Kaseb, Rachna T, Shroff
Publikováno v:
Journal of gastrointestinal oncology. 5(6)
Gemcitabine plus platinum (GEM-P) combination chemotherapy is standard treatment for first-line advanced cholangiocarcinoma (aCC). GEM-P first-line therapy reports a progression-free survival (PFS) of 8 months and overall survival (OS) of 11.7 months
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3492050ecd9890271cd8871a90b120f9
https://pubmed.ncbi.nlm.nih.gov/25436118
https://pubmed.ncbi.nlm.nih.gov/25436118
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Case Study Mr. D., a 55-year-old male, presented to the medical oncology service with a diagnosis of stage III adenocarcinoma of the sigmoid colon. He presented 7 weeks post sigmoid colectomy with lymph node resection and was initiated on adjuvant ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0399dd7bded3778c037ce5ae209af079
https://doi.org/10.6004/jadpro.2014.5.3.5
https://doi.org/10.6004/jadpro.2014.5.3.5
Autor:
Milind Javle, D. Van Nguyen, Ahmed Omar Kaseb, Wei Qiao, Lindsey Law, Rachna T. Shroff, Jane E. Rogers
Publikováno v:
Journal of Clinical Oncology. 32:371-371
371 Background: Five-year survival for advanced cholangiocarcinoma (aCC) is reported at 5-10%. For advanced, unresectable patients, gemcitabine plus platinum (GEM-P) combination chemotherapy is common practice as first-line treatment with progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67df30702a56bae7f54b112d17aa7166
https://doi.org/10.1200/jco.2014.32.3_suppl.371
https://doi.org/10.1200/jco.2014.32.3_suppl.371
Autor:
Najwa Khuri-Bulos, Lindsey Lawrence, Bhinnata Piya, Li Wang, Christopher Fonnesbeck, Samir Faouri, Asem Shehabi, Sten H. Vermund, John V. Williams, Natasha B. Halasa
Publikováno v:
Journal of Infection and Public Health, Vol 13, Iss 3, Pp 460- (2020)
Externí odkaz:
https://doaj.org/article/0626665793d04a5e8e5fe34220a05baa